Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: Prospective and randomized study

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 4, 2003, Pages 587-594

  Peraaho M ^a,b   Kaukinen, K ^a,b   Paasikivi, K ^a,b   Sievanen H ^c   Lohiniemi, S ^d   Maki M ^a,b   Collin, P ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^d Finnish Coeliac Society   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN ANTIBODY; GLUTEN; HLA DR ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; STARCH;

ADULT; ARTICLE; BONE MINERAL; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; GLUTEN FREE DIET; HUMAN; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; SMALL INTESTINE; WHEAT;

ADULT; AGED; BONE DENSITY; CELIAC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; STARCH; TRITICUM;

EID: 17144467156     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01425.x     Document Type: Article

References (36)

1. Valdimarsson T. Toss G, Ross I, Lofman O. Ström M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994: 29: 457-61.
2. Walters JR. Bone mineral density in coeliac disease. Gut 1994; 35: 150-1.
3. Cellier C, Flobert C, Cormier C, Roux C. Schmitz J. Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease. Lancet 2000; 355: 806.
4. Holmes GKT, Prior P. Lane MR. Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989: 30: 333-8.
5. Corrao G. Corazza GR. Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001: 358: 356-61.
6. Codex-Alimentarius-Commission. Codex Standard. Joint FAO/WHO Food Standards Programme. Rome: WHO. 1981: 118.
7. Skerritt JH. Hill AS. How 'free' is 'gluten free'? Relationship between Kjeldahl nitrogen values and gluten protein content for wheat starches. Cereal Chem 1992: 69: 110-2.
8. Hekkens WT. The evolution in research in prolamin toxicity:from bread to peptide. Bibl Nutr Dieta 1991; 48: 90-104.
9. Chartrand LJ, Russo PA, Duhaime AG, Seidman EG. Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc 1997: 97: 612-8.
10. Ejderhamn J. Veress B. Strandvik B. The long-term effect of continual ingestion of wheat starch-containing gluten-free products in coeliac patients. In: Kumar PJ. ed. Coeliac Disease: One Hundred Years. Leeds: Leeds University Press, 1988: 294-7.
11. Kaukinen K. Collin P. Holm K, et al. Wheat starch-containing gluten-free flour products in the treatment of coeliac disease and dermatitis herpetiformis. A long-term follow-up study. Scand J Gastroenterol 1999: 34: 164-9.
12. Lohiniemi S. Mäki M, Kaukinen K, Laippala P. Collin P. Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diet. Scand J Gastroenterol 2000: 35: 947-9.
13. Selby WS, Painter D, Collins A, Faulkner-Hogg KB, Loblay RH. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol 1999: 34: 909-14.
14. Montgomery AM. Goka AK, Kumar PJ, Farthing MJ. Clark ML. Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies. Gut 1988; 29: 1564-8.
15. Catassi C. Rossini M, Rätsch I-M. et al. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 1993: 34: 1515-9.
16. Ciclitira PJ, Ellis HJ. Fagg NL. Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease. Br Med J 1984: 289: 83.
17. Ciclitira PJ. Cerio R. Ellis HJ. et al. Evaluation of a gliadin-containing gluten-free product in coeliac patients. Hum Nutr Clin Nutr 1985: 39C: 303-8.
18. Ciclitira PJ, Evans DJ. Fagg NL, Lennox ES. Dowling RH. Clinical testing of gliadin fractions in coeliac patients. Clin Sci 1984: 66: 357-64.
19. Thompson T. Wheat starch, gliadin, and the gluten-free diet. J Am Diet Assoc 2001; 101: 1456-9.
20. Armitage P, Berry G, eds. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1987: 522.
21. Kuitunen P, Kosnai I, Savilahti E. Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr 1982; 1: 525-31.
22. Arranz E. Bode J. Kingstone K, Ferguson A. Intestinal antibody pattern of coeliac disease: association with gamma/delta T cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease. Gut 1994; 35: 476-82.
23. Savilahti E. Reunala T. Mäki M. Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis. Gut 1992: 33: 206-11.
24. Holm KH. Correlation of HLA-DR alleles to jejunal mucosal morphology in healthy first-degree relatives of coeliac disease patients. Eur J Gastroenterol Hepatol 1993: 5: 35-9.
25. Ladinser B. Rossipal E. Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-8
26. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998: 115: 1322-8.
27. Vainio E. Kalimo K. Reunala T. Viander M. Palosuo T. Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay. Arch Dermatol Res 1983: 275: 15-8.
28. Dimenäs E, Carlsson H, Glise H, Israelsson B. Wiklund I. Relevance of normal values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996: 31(Suppl.): 8-13.
29. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988: 33: 129-34.
30. Grefte JM, Bouman JG. Grond J, Jansen W, Kleibeuker JH. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988: 41: 886-91.
31. Mayer M, Greco L, Troncone R, Auricchio S, Marsh MN. Compliance of adolescents with coeliac disease with a gluten free diet. Gut 1991: 32: 881-5.
32. Leigh RJ. Marsh MN, Crowe P, et al. Studies of intestinal lymphoid tissue. IX. Dose-dependent, gluten-induced lymphoid infiltration of coeliac jejunal epithelium. Scand J Gastroenterol 1985: 20: 715-9.
33. Savilahti E, Arato A. Verkasalo M. Intestinal gamma/delta receptor-bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease. Pediatr Res 1990: 28: 579-81.
34. Kutlu T, Brousse N, Rambaud C. et al. Numbers of T cell receptor (TcR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 1993: 34: 208-14.
35. Iltanen S, Holm K. Ashorn M, et al. Changing jejunal gamma delta T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol 1999; 117: 51-5.
36. Faulkner-Hogg KB. Selby WS, Loblay RH. Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten products. Scand J Gastroenterol 1999: 34: 784-9.